Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001
NCT02868229
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Anemia
Interventions
DRUG:
COR-001
OTHER:
Placebo
Sponsor
Novo Nordisk A/S